meddevicedb.com FDA Device Reference

ONTRAK TESTSTIK 3 FOR COCAINE/MORPHINE/THC,CAT. 1118595

K994165 Class II Traditional
Decision Date
2000-04-07
Sponsor / Applicant
Roche Diagnostics Corp.

Technical Specification

510(k) Submission ID K994165
Product Code DIO
Medical Specialty / Panel Clinical Toxicology
Regulation Citation 21 CFR 862.3250
Decision Date 2000-04-07
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

ONTRAK TESTSTIK 3 FOR COCAINE/MORPHINE/THC,CAT. 1118595 received FDA 510(k) clearance under submission number K994165, sponsored by Roche Diagnostics Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Toxicology review panel. The statutory decision date of record is 2000-04-07.

Classification & Regulation

This clearance is catalogued under FDA product code DIO and 21 CFR 862.3250, within the Clinical Toxicology review panel as a Class II device.